0001209191-23-026991.txt : 20230503 0001209191-23-026991.hdr.sgml : 20230503 20230503164420 ACCESSION NUMBER: 0001209191-23-026991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230501 FILED AS OF DATE: 20230503 DATE AS OF CHANGE: 20230503 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bhatia Sangeeta N. CENTRAL INDEX KEY: 0001643921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 23884883 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS, INC. STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001643921 Bhatia Sangeeta N. C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 0 0 0 1 Common Stock 2023-05-01 4 A 0 1168 0.00 A 5208 D Common Stock 2023-05-02 4 S 0 62 345.93 D 5146 D Common Stock 2023-05-02 4 S 0 172 346.69 D 4974 D Common Stock 2023-05-02 4 S 0 120 348.16 D 4854 D Common Stock 2023-05-02 4 S 0 163 349.82 D 4691 D Common Stock 2023-05-02 4 S 0 63 351.20 D 4628 D Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1, which was entered into on 05/17/2022. Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $345.93 (range $345.20 to $346.12). Open market sales reported on this line occurred at a weighted average price of $346.69 (range $346.31 to $347.03). Open market sales reported on this line occurred at a weighted average price of $348.16 (range $347.91 to $348.64). Open market sales reported on this line occurred at a weighted average price of $349.82 (range $349.17 to $350.08). Open market sales reported on this line occurred at a weighted average price of $351.20 (range $350.92 to $351.48). /s/ Christiana Stevenson, Attorney-in-Fact 2023-05-03